149 related articles for article (PubMed ID: 33573552)
1. Identification and Analysis of RNA Editing Events in Ovarian Serous Cystadenoma Using RNA-seq Data.
Wang Y; Song X; Xu T
Curr Gene Ther; 2021; 21(3):258-269. PubMed ID: 33573552
[TBL] [Abstract][Full Text] [Related]
2. The role of A-to-I RNA editing in cancer development.
Xu X; Wang Y; Liang H
Curr Opin Genet Dev; 2018 Feb; 48():51-56. PubMed ID: 29127844
[TBL] [Abstract][Full Text] [Related]
3. Landscape of tissue-specific RNA Editome provides insight into co-regulated and altered gene expression in pigs (
Adetula AA; Fan X; Zhang Y; Yao Y; Yan J; Chen M; Tang Y; Liu Y; Yi G; Li K; Tang Z
RNA Biol; 2021 Oct; 18(sup1):439-450. PubMed ID: 34314293
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
5. Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.
Gu T; Fu AQ; Bolt MJ; White KP
JCO Clin Cancer Inform; 2019 Jun; 3():1-8. PubMed ID: 31162949
[TBL] [Abstract][Full Text] [Related]
6. A-to-I editing in the miRNA seed region regulates target mRNA selection and silencing efficiency.
Kume H; Hino K; Galipon J; Ui-Tei K
Nucleic Acids Res; 2014 Sep; 42(15):10050-60. PubMed ID: 25056317
[TBL] [Abstract][Full Text] [Related]
7. RNA editing of human microRNAs.
Blow MJ; Grocock RJ; van Dongen S; Enright AJ; Dicks E; Futreal PA; Wooster R; Stratton MR
Genome Biol; 2006; 7(4):R27. PubMed ID: 16594986
[TBL] [Abstract][Full Text] [Related]
8. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
Wang Y; Xu X; Yu S; Jeong KJ; Zhou Z; Han L; Tsang YH; Li J; Chen H; Mangala LS; Yuan Y; Eterovic AK; Lu Y; Sood AK; Scott KL; Mills GB; Liang H
Genome Res; 2017 Jul; 27(7):1112-1125. PubMed ID: 28411194
[TBL] [Abstract][Full Text] [Related]
9. The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.
Tassinari V; Cesarini V; Silvestris DA; Gallo A
Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):291-300. PubMed ID: 30605729
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Characterization of RNA Editing Sites in Primary Gastric Adenocarcinoma through RNA-seq Data Analysis.
Behroozi J; Shahbazi S; Bakhtiarizadeh MR; Mahmoodzadeh H
Int J Genomics; 2020; 2020():6493963. PubMed ID: 33415135
[TBL] [Abstract][Full Text] [Related]
11. Systematic identification of edited microRNAs in the human brain.
Alon S; Mor E; Vigneault F; Church GM; Locatelli F; Galeano F; Gallo A; Shomron N; Eisenberg E
Genome Res; 2012 Aug; 22(8):1533-40. PubMed ID: 22499667
[TBL] [Abstract][Full Text] [Related]
12. LNCediting: a database for functional effects of RNA editing in lncRNAs.
Gong J; Liu C; Liu W; Xiang Y; Diao L; Guo AY; Han L
Nucleic Acids Res; 2017 Jan; 45(D1):D79-D84. PubMed ID: 27651464
[TBL] [Abstract][Full Text] [Related]
13. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
[TBL] [Abstract][Full Text] [Related]
14. Adenosine-to-inosine RNA editing.
Zinshteyn B; Nishikura K
Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
[TBL] [Abstract][Full Text] [Related]
15. ADeditome provides the genomic landscape of A-to-I RNA editing in Alzheimer's disease.
Wu S; Yang M; Kim P; Zhou X
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33401309
[TBL] [Abstract][Full Text] [Related]
16. A-to-I editing of coding and non-coding RNAs by ADARs.
Nishikura K
Nat Rev Mol Cell Biol; 2016 Feb; 17(2):83-96. PubMed ID: 26648264
[TBL] [Abstract][Full Text] [Related]
17. Large-scale prediction of ADAR-mediated effective human A-to-I RNA editing.
Yao L; Wang H; Song Y; Dai Z; Yu H; Yin M; Wang D; Yang X; Wang J; Wang T; Cao N; Zhu J; Shen X; Song G; Zhao Y
Brief Bioinform; 2019 Jan; 20(1):102-109. PubMed ID: 28968662
[TBL] [Abstract][Full Text] [Related]
18. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
19. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome-wide identification of A-to-I RNA editing sites using ICE-seq.
Okada S; Ueda H; Noda Y; Suzuki T
Methods; 2019 Mar; 156():66-78. PubMed ID: 30578846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
